Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
about
Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventionsESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryLipoexpediency: de novo lipogenesis as a metabolic signal transmitterGut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese IndividualsRole of BAF60a/BAF60c in chromatin remodeling and hepatic lipid metabolismNovel Molecular Mechanisms in the Development of Non-Alcoholic SteatohepatitisResearch advances in the relationship between nonalcoholic fatty liver disease and atherosclerosisPharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell PhenotypeObesity and insulin resistance: an abridged molecular correlationMicroRNAs as controlled systems and controllers in non-alcoholic fatty liver diseaseRole of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver diseaseContributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancerRole of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver diseaseLow-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver diseaseRole of mitochondria in nonalcoholic fatty liver diseaseGender and Obesity Specific MicroRNA Expression in Adipose Tissue from Lean and Obese PigsVitamin D: a new player in non-alcoholic fatty liver disease?Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic StrategiesTumor suppressor Menin acts as a corepressor of LXRα to inhibit hepatic lipogenesis12- and 15-lipoxygenases in adipose tissue inflammationInteractions between inflammation, sex steroids, and Alzheimer's disease risk factorsCoordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primatesLabel-free evaluation of hepatic microvesicular steatosis with multimodal coherent anti-Stokes Raman scattering microscopyThe Mammalian "Obesogen" Tributyltin Targets Hepatic Triglyceride Accumulation and the Transcriptional Regulation of Lipid Metabolism in the Liver and Brain of ZebrafishAcetylshikonin from Zicao Prevents Obesity in Rats on a High-Fat Diet by Inhibiting Lipid Accumulation and Inducing LipolysisPerspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future TherapiesEconomic Burden of Obesity: A Systematic Literature ReviewHigh-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver DiseaseNon-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease.Liver failure in an obese middle-aged woman after biliointestinal bypass.Assessment of causality between serum gamma-glutamyltransferase and type 2 diabetes mellitus using publicly available data: a Mendelian randomization study.Synthesis and anti-obesity effects in vivo of Crotadihydrofuran C as a novel PPARγ antagonist from Crotalaria albidaFructose Consumption in the Development of Obesity and the Effects of Different Protocols of Physical Exercise on the Hepatic MetabolismMetabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis.Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.Hepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in Mice.Urinary loss of tricarboxylic acid cycle intermediates as revealed by metabolomics studies: an underlying mechanism to reduce lipid accretion by whey protein ingestion?Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies.The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study.
P2860
Q21285128-35317EDA-C6EA-45ED-A9AE-33A58EA08DB1Q22241786-0C764A66-FBA0-49C8-A126-532CC01F18A3Q24620189-1715D39C-6ECE-492D-B919-E5786C6F51F3Q26748972-801BBB73-9CF3-435A-97C9-42E4293D226CQ26749020-7E286F6F-5DA4-44EF-90AD-27AC75CDF69BQ26766533-AC6119E3-2F83-4C2B-8A31-DF2561D68950Q26775340-96584C3D-E627-41C1-93E7-271B3001EDEBQ26779198-F7D7D730-4622-4EDC-A956-0808DC7DDEB2Q26825473-C9E7E0EF-9B22-47F0-8696-B5D5A0D700E7Q26852606-9E26DB01-BB0B-4D40-A3AB-3DA92DFFEA2DQ26853645-EE13A31D-83F5-4A26-BC45-228F8B4E5DA9Q26992106-BEC218FC-CAEA-4506-9AF3-9950FD1942FAQ27005988-855EDCDD-059E-4D08-8D2F-A3856B975D28Q27007233-A2E98FBC-77D2-499B-A2CE-0EAFFE817FC9Q27028142-BC5E2359-F489-4581-9650-096E88AC27BBQ27303508-0FCA6DB3-C45D-4E09-A24C-EDF5BD1748CAQ28081391-69983EB6-F3BD-45F4-A2CF-8ADDC031DF0CQ28088325-4F2D5BE5-AEDE-45A5-9A40-85EAB4F0E2A1Q28114881-8992AA76-A694-4B2C-8BEF-747F617CE509Q28274315-0A11C110-5525-4591-AA2F-EE15D8765DE7Q28394967-DF8F81C1-C184-43DC-A2E5-E7F63210395BQ28478084-C4DC0F8A-BAA5-4781-90D5-8E82876BB4DFQ28485412-D7268858-7CCF-4F13-9207-66DB195938A2Q28551300-D58C3916-1D43-476C-8BB4-C8A55221E2E5Q28552550-D7EDD5B2-A1A1-436D-9E99-17551BBB81CCQ30234444-BDA696F3-F6C4-4BCE-BDBF-7FD9D2213CCDQ30234748-AAA11F36-7CE4-470B-BDEC-153386C6832DQ30362727-5885F8E7-9387-4808-A717-977C4C743DD4Q30401022-D13FA148-D992-43E2-85E5-63470F88DBA0Q30437623-74EF6E6F-1C56-4429-A203-689DD5ACA54EQ30446406-43CC665A-8ED6-4731-B63C-FFC2D0C2117FQ31151847-6D9A7FC5-3C27-49BF-9422-F926BE8D4157Q33594205-3B8621ED-F0F1-4D50-B09C-FFFCD5279862Q33616976-C9072952-F39A-4697-86C3-1CFF15E29AD2Q33631151-3AD5A57E-57C5-4B45-B896-3CD38FF69BB1Q33640536-802A78A3-4855-43D3-8E35-BBE31360D5CFQ33669422-0489498A-0286-4060-A965-C5DEE2C7F406Q33709740-0F8D1ECD-C025-401A-A1A3-A6CE65BC9F03Q33749608-B1FEDA52-B42F-44F1-8532-3CF6949B14EFQ33757419-A7EF53B0-BFD3-4133-8CDD-92C4521F6AE7
P2860
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Obesity and nonalcoholic fatty ...... lic, and clinical implications
@ast
Obesity and nonalcoholic fatty ...... lic, and clinical implications
@en
type
label
Obesity and nonalcoholic fatty ...... lic, and clinical implications
@ast
Obesity and nonalcoholic fatty ...... lic, and clinical implications
@en
prefLabel
Obesity and nonalcoholic fatty ...... lic, and clinical implications
@ast
Obesity and nonalcoholic fatty ...... lic, and clinical implications
@en
P2093
P2860
P356
P1433
P1476
Obesity and nonalcoholic fatty ...... lic, and clinical implications
@en
P2093
Elisa Fabbrini
Samuel Klein
Shelby Sullivan
P2860
P304
P356
10.1002/HEP.23280
P407
P577
2010-02-01T00:00:00Z